Skip to main content
. 2017 Oct 10;23:695–706.

Table 2. Additional IRD gene variants in CACNA1F patients.

Patient ID Gene Transcript Zygosity cDNA position Protein change Polyphen-2 SIFT Provean MutationTaster dbSNP ExAC Frequency
1
SEMA4A
NM_022367.3
heterozygous
c.2138G>A
p.(Arg713Gln)
Possibly damaging
Tolerated
Neutral
Polymorphism
rs41265017
A=4,297/ G=121,356
PDE6A
NM_000440.2
heterozygous
c.251A>T
p.(Lys84Met)
Benign
Damaging
Deleterious
Polymorphism
NA
T=11/ A=121,396
PDE6B
NM_000283.3
heterozygous
c.1412C>T
p.(Ala471Val)
Benign
Damaging
Neutral
Polymorphism
rs182071364
T=17/ C=119,914
RPGR a
NM_001034853.1
hemizygous
c.1163C>T
p.(Ala388Val)
Benign
Tolerated
Neutral
Polymorphism
rs199661899
T=16/ C=85,833
2 USH2A
NM_206933.2
heterozygous
c.9286G>A
p.(Val3096Met)
Probably damaging
Damaging
Neutral
Polymorphism
rs147267500
A=6/ G=121,394
PDE6A NM_000440.2 heterozygous c.1214A>G p.(Asn405Ser) Probably damaging Damaging Deleterious Disease causing rs145107955 G=20/ A=121,278

a Known polymorphism reported in [71].